TPPP3 Associated with Prognosis and Immune Infiltrates in Head and Neck Squamous Carcinoma

Table 2

The relationship between the expression of TPPP3 and the clinicopathological features of nasopharyngeal carcinoma.

Group		Negative (-)	Positive (+)	Positive proportion (%)	value
Gender
Male	41	36	5	12.20	>0.05
Female	16	14	2	12.50
Age
≤45	25	24	3	12.00	>0.05
>45	32	28	4	12.50
Differentiation or not
Differentiated	6	5	1	16.67	>0.05
Undifferentiated	51	45	6	11.76
T stage
T1, T2	21	19	2	9.52	>0.05
T3, T4	36	31	5	13.89
N stage
≥N1	52	46	6	11.54	>0.05
N0	5	4	1	20.00
M stage
M0	49	43	6	12.24	>0.05
M1	8	7	1	12.50
Clinical stage
I, II	5	4	1	20.00	>0.05
III, IV	52	46	6	11.54